New drug can have a promising effect in cancer patients with active brain metastases

[News]

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of various tumor types.

More... (https://www.news-medical.net/news/20251028/New-drug-can-have-a-promising-effect-in-cancer-patients-with-active-brain-metastases.aspx)